These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1621013)

  • 1. ["Toxins" and nerve--a discussion on the pathogenesis of acrylamide intoxication, giant axonal neuropathy and Krabbe disease].
    Igisu H
    J UOEH; 1992 Jun; 14(2):185-92. PubMed ID: 1621013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axonopathy is a compounding factor in the pathogenesis of Krabbe disease.
    Castelvetri LC; Givogri MI; Zhu H; Smith B; Lopez-Rosas A; Qiu X; van Breemen R; Bongarzone ER
    Acta Neuropathol; 2011 Jul; 122(1):35-48. PubMed ID: 21373782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Giant axonal neuropathy--comparing with acrylamide poisoning].
    Igisu H; Inoue N; Goto I
    Fukuoka Igaku Zasshi; 1990 Apr; 81(4):163-9. PubMed ID: 2199360
    [No Abstract]   [Full Text] [Related]  

  • 4. Intrinsic resistance of neural stem cells to toxic metabolites may make them well suited for cell non-autonomous disorders: evidence from a mouse model of Krabbe leukodystrophy.
    Taylor RM; Lee JP; Palacino JJ; Bower KA; Li J; Vanier MT; Wenger DA; Sidman RL; Snyder EY
    J Neurochem; 2006 Jun; 97(6):1585-99. PubMed ID: 16805770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural studies of the dying-back process. IV. Differential vulnerability of PNS and CNS fibers in experimental central-peripheral distal axonopathies.
    Spencer PS; Schaumburg HH
    J Neuropathol Exp Neurol; 1977; 36(2):300-20. PubMed ID: 190358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive accumulation of toxic metabolite in a genetic leukodystrophy.
    Igisu H; Suzuki K
    Science; 1984 May; 224(4650):753-5. PubMed ID: 6719111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and morphological findings in acrylamide toxicity.
    Le Quesne PM
    Neurotoxicology; 1985; 6(4):17-24. PubMed ID: 4088539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acrylamide neuropathy: selective vulnerability of sensory fibers.
    Sumner AJ; Asbury AK
    Trans Am Neurol Assoc; 1974; 99():79-83. PubMed ID: 4377051
    [No Abstract]   [Full Text] [Related]  

  • 9. A galactose-free diet enriched in soy isoflavones and antioxidants results in delayed onset of symptoms of Krabbe disease in twitcher mice.
    Pannuzzo G; Cardile V; Costantino-Ceccarini E; Alvares E; Mazzone D; Perciavalle V
    Mol Genet Metab; 2010 Jul; 100(3):234-40. PubMed ID: 20418135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nervous system degeneration produced by acrylamide monomer.
    Spencer PS; Schaumburg HH
    Environ Health Perspect; 1975 Jun; 11():129-33. PubMed ID: 170076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.
    Nogueira-Rodrigues J; Brites P; Sousa MM
    J Neurosci Res; 2016 Nov; 94(11):1037-41. PubMed ID: 27638589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmyelinated nerve fibres in feline acrylamide neuropathy.
    Post EJ
    Acta Neuropathol; 1978 Apr; 42(1):19-24. PubMed ID: 207070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Giant axonal neuropathy" caused by industrial chemicals: neurofilamentous axonal masses in man.
    Davenport JG; Farrell DF; Sumi M
    Neurology; 1976 Oct; 26(10):919-23. PubMed ID: 183168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Krabbe disease (globoid cell leukodystrophy)].
    Sakai N; Inui K; Okada S
    Nihon Rinsho; 1995 Dec; 53(12):2947-51. PubMed ID: 8577041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acrylamide neuropathy: changes in the composition of proteins of fast axonal transport resemble those observed in regenerating axons.
    Bisby MA; Redshaw JD
    J Neurochem; 1987 Mar; 48(3):924-8. PubMed ID: 2433402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acrylamide and polyacrylamide: a review of production, use, environmental fate and neurotoxicity.
    Smith EA; Oehme FW
    Rev Environ Health; 1991; 9(4):215-28. PubMed ID: 1668792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty five years of the "psychosine hypothesis": a personal perspective of its history and present status.
    Suzuki K
    Neurochem Res; 1998 Mar; 23(3):251-9. PubMed ID: 9482237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal sprouting of motor nerve in acrylamide-intoxicated rats with progressive weakness.
    Madrid RG; Ohnishi A; Hachisuka K; Murai Y
    Environ Res; 1993 Feb; 60(2):233-41. PubMed ID: 8472652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Pathogenesis and Treatment of Krabbe Disease.
    Bongarzone ER; Escolar ML; Gray SJ; Kafri T; Vite CH; Sands MS
    Pediatr Endocrinol Rev; 2016 Jun; 13 Suppl 1():689-96. PubMed ID: 27491217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of psychosine on inducible nitric-oxide synthase expression under different culture conditions: implications for Krabbe disease.
    Bashir A; Haq E
    Eur Rev Med Pharmacol Sci; 2011 Nov; 15(11):1282-7. PubMed ID: 22195360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.